Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Pharma Intermediate. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN112125840B reveals a novel Pd-catalyzed method using CO2 for diaryl ether synthesis, offering mild conditions and cost reduction in pharmaceutical manufacturing.
Patent CN107805216A reveals a novel copper-catalyzed route for chiral tetrahydropyrrole intermediates, offering superior enantioselectivity and scalable manufacturing advantages.
Patent CN103619815A details a high-yield four-step synthesis for proline compounds. This method offers significant cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing.
Patent CN118684634A reveals efficient synthesis. High yield and selectivity for pharmaceutical intermediates. Reliable supply chain and cost reduction.
Patent CN119192176B reveals a mild silver-catalyzed route for polysubstituted pyrrolo isoquinoline intermediates, offering significant cost and supply chain advantages for pharmaceutical manufacturing.
Novel diazotization route for 1-hydroxycyclopropanecarboxylic acid offers higher yields and safer scale-up for pharmaceutical intermediates.
Patent CN109053528A reveals a safer Levetiracetam route avoiding toxic reagents. This enhances supply chain reliability and reduces manufacturing costs significantly.
Patent CN106554265A reveals a one-step Lewis acid catalyzed route for 1-benzosuberones offering high purity and simplified manufacturing for global pharmaceutical supply chains.
Patent CN102260272B details high-purity Irinotecan synthesis. Eliminates pyridine, improves yield, ensures supply chain reliability for pharmaceutical manufacturers globally.
Novel patent CN116621742B route for oxopyridine compounds. Enhances selectivity and yield for pharmaceutical intermediates. Reliable supply chain partner.
Patent CN110818584B reveals a metal-free visible light method for synthesizing alpha,beta-unsaturated amides, offering cost reduction and scalable pharmaceutical intermediate manufacturing.
Novel separation method for high-purity iQ[7] using ion exchange resin. Reduces complexity in supramolecular material manufacturing and ensures supply continuity.
Novel Pd-catalyzed synthesis avoids toxic CO gas usage. High yield 77%. Reliable supply chain for sulfur-containing heterocycles and pharmaceutical intermediates manufacturing.
Patent CN116925093A details a refined irinotecan synthesis using 1-methylpyrrolidine. This method offers cost reduction and scalable manufacturing for pharmaceutical intermediates.
Patent CN111704531B reveals a cost-effective iron-catalyzed route for beta-aryl-alpha-naphthols, replacing expensive noble metals for scalable pharmaceutical intermediate manufacturing.
Patent CN115894526A reveals a green electrochemical route for benzimidazolo oxathiazine derivatives, offering cost reduction and scalable manufacturing for pharmaceutical intermediates.
Patent CN112624921A reveals a novel Grignard-based synthesis for 1-hydroxymethyl cyclopropyl acetic acid, offering significant cost reduction and safety improvements for Montelukast manufacturing.
Patent CN102304007B reveals high-ee asymmetric hydrogenation using chiral Ru catalysts enabling cost reduction in pharmaceutical intermediate manufacturing with scalable processes.
Patent CN107460497A enables cost-effective electrochemical Minisci acylation. Eliminate silver catalysts for scalable pharmaceutical intermediate manufacturing.
Patent CN103641758A details a cost-effective D,L-methionine preparation using unpurified methional and HCN gas, offering high yield and supply chain advantages.